Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunogenicity”

6,245 trials

Showing 20 of 6,245 results

Early research (Phase 1)Study completedNCT01889836
What this trial is testing

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Who this might be right for
Meningitis, Meningococcal, Serogroup C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 60
Early research (Phase 1)Study completedNCT00043511
What this trial is testing

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Post-approval studies (Phase 4)Study completedNCT02274792
What this trial is testing

Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 132
Large-scale testing (Phase 3)Study completedNCT06011200
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 1,000
Early research (Phase 1)Study completedNCT01070407
What this trial is testing

A New Candidate Vaccine Against Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
ReiThera Srl 41
Testing effectiveness (Phase 2)Study completedNCT01982292
What this trial is testing

Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 321
Early research (Phase 1)Study completedNCT00942071
What this trial is testing

Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults

Who this might be right for
Influenza
University of Oxford 58
Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT01307436
What this trial is testing

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

Who this might be right for
Hepatitis A
Crucell Holland BV 327
Large-scale testing (Phase 3)Study completedNCT00992511
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults, Using Two Different Manufacturing Processes

Who this might be right for
Influenza
GlaxoSmithKline 300
Early research (Phase 1)Study completedNCT05739292
What this trial is testing

Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old

Who this might be right for
Infection, Meningococcal
EuBiologics Co.,Ltd 60
Post-approval studies (Phase 4)Study completedNCT01392378
What this trial is testing

Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®

Who this might be right for
Pneumococcal Vaccines
Pfizer 908
Not applicableLooking for participantsNCT05571735
What this trial is testing

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Who this might be right for
Covid-19 PandemicsTuberculosis
University of Oxford 133
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827768
What this trial is testing

Phase 2 Study of AV-1959R in Individuals With Preclinical Alzheimer's Disease

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer Disease
Institute for Molecular Medicine 160
Early research (Phase 1)Study completedNCT02376426
What this trial is testing

Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 72
Testing effectiveness (Phase 2)WithdrawnNCT05950776
What this trial is testing

COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults

Who this might be right for
Covid19
Universitätsklinikum Hamburg-Eppendorf
Not applicableStudy completedNCT04665791
What this trial is testing

A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults

Who this might be right for
Meningitis, Meningococcal
Center for Vaccine Development - Mali 55
Large-scale testing (Phase 3)Study completedNCT06497491
What this trial is testing

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

Who this might be right for
Still's Disease Adult Onset
AO GENERIUM 118
Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation